TP53 and cancer: Mutant p53 has been suggested to be partially inhibited by hetero-oligomerization with wt p53 [19] and several groups have shown that the presence of the expressed wt TP53 allele is limiting the tumor occurrence driven by p53 mutants in cancer models in vivo [20–23].